| Meta-analysis of therapeutic hypothermia for traumatic brain injury in adult and pediatric patients EM Crompton, I Lubomirova, I Cotlarciuc, TS Han, SD Sharma, P Sharma Critical care medicine 45 (4), 575-583, 2017 | 122 | 2017 |
| Genetic therapeutic advancements for Dravet syndrome E Chilcott, JA Díaz, C Bertram, M Berti, R Karda Epilepsy & Behavior 132, 108741, 2022 | 34 | 2022 |
| Systematic review and meta-analysis determining the benefits of in vivo genetic therapy in spinal muscular atrophy rodent models EM Chilcott, EW Muiruri, TC Hirst, RJ Yáñez-Muñoz Gene Therapy 29 (9), 498-512, 2022 | 7 | 2022 |
| Enhanced expression of the human Survival motor neuron 1 gene from a codon-optimised cDNA transgene in vitro and in vivo NAM Nafchi, EM Chilcott, S Brown, HR Fuller, M Bowerman, ... Gene Therapy 30 (12), 812-825, 2023 | 4 | 2023 |
| AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn2B/− spinal muscular atrophy mice SJ Brown, D Šoltić, SA Synowsky, SL Shirran, E Chilcott, HK Shorrock, ... Human Molecular Genetics 32 (20), 2950-2965, 2023 | 3 | 2023 |
| AAV9-mediated targeting of natural antisense transcript as a novel treatment for Dravet Syndrome JF Antinao Diaz, E Chilcott, A Almacellas Barbanoj, A Keegan, ... bioRxiv, 2024.09. 27.615323, 2024 | | 2024 |
| Spinal cord pathology in a Dravet Syndrome mouse model AD JF, E Chilcott, A Keegan, S Schorge, SN Waddington, R Karda | | 2023 |
| Spinal cord pathology in a Dravet Syndrome mouse model J Antinao Diaz, E Chilcott, A Keegan, S Schorge, SN Waddington, ... bioRxiv, 2023.09. 22.558962, 2023 | | 2023 |
| Correction: Systematic review and meta-analysis determining the benefits of in vivo genetic therapy in spinal muscular atrophy rodent models EM Chilcott, EW Muiruri, TC Hirst, RJ Yáñez-Muñoz Gene Therapy 30 (1), 188-188, 2023 | | 2023 |
